EMD273316 & EMD95833, type 4 phosphodies
โ
Andrew Scutt; Norbert Beier; Claus Fittschen
๐
Article
๐
2004
๐
BioMed Central
๐
English
โ 538 KB
Background: Type 4 phosphodiesterase (PDE4) inhibitors have been shown to stimulate bone formation in vivo and to stimulate osteoblastic differentiation in vitro. As one possible mechanism for the stimulation of bone formation is the recruitment of osteoprogenitor cells from the bone marrow, we have